MC38 murine colon cancer [28] were previously characterized as responders to anti-PD-1 therapies [21], and murine melanoma B16-hCXCR4 previously defined as poor immune responsive tumors [22, 24, 29]. The gene discussed is PDCD1; the disease is malignant colon neoplasm.